Showing results (241-250 of 249) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 249 results.
The Journal of Biological Chemistry|April 12, 2001
Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptorD G Gilbertson, M E Duff, J W West, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 21, 2017
Cervical funneling or intra-amniotic debris and preterm birth in nulliparous women with midtrimester cervical length less than 30 mmG R Saade, E A Thom, W A Grobman, et al.
Arthritis Research & Therapy|March 23, 2010
B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulinStacey R Dillon, Brandon Harder, Kenneth B Lewis, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 29, 2009
Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER TrialM E D'Alton, J Cleary-Goldman, G Lambert-Messerlian, et al.
British Journal of Cancer|June 19, 2015
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinomaM E Gore, C Szczylik, C Porta, et al.
European Journal of Immunology|March 19, 2011
Vstm3 is a member of the CD28 family and an important modulator of T-cell functionSteven D Levin, David W Taft, Cameron S Brandt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17FRolf E Kuestner, David W Taft, Aaron Haran, et al.
Protein Engineering, Design & Selection : PEDS|December 22, 2009
Engineering of stable bispecific antibodies targeting IL-17A and IL-23Robert Mabry, Katherine E Lewis, Margaret Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2015
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†A Kramar, S Negrier, R Sylvester, et al.
Pageof 25